Other Content - BioPharm International

ADVERTISEMENT

Other Content

Agilent - Analysis of Polyethylene Glycol (PEG) and a Mono and Di-PEGylated Therapeutic Protein Using HPLC and Q-TOF Mass Spectrometry

May 17, 2013

Agilent - Analysis of Polyethylene Glycol (PEG) and a Mono and Di-PEGylated Therapeutic Protein Using HPLC and Q-TOF Mass Spectrometry

Kalypso - Driving Innovation in BioPharma with Product Lifecycle Management

May 16, 2013

Kalypso - Driving Innovation in BioPharma with Product Lifecycle Management

Legislation to Protect Subjects in Clinical Trials Introduced

May 16, 2013

Legislation designed to protect clinical trial study participants, close loopholes, and bring certainty and public transparency to research studies, has been introduced.

Fluid Imaging Technologies - Automated Fiber Particle Imaging and Characterization Including Differentiating Fiber Curl from Straightness

May 16, 2013

Fluid Imaging Technologies - Automated Fiber Particle Imaging and Characterization Including Differentiating Fiber Curl from Straightness

Agilent - Characterization of Glycosylation in the Fc Region of Therapeutic Recombinant Monoclonal Antibody

May 16, 2013

Agilent - Characterization of Glycosylation in the Fc Region of Therapeutic Recombinant Monoclonal Antibody

Wyatt - Automated Dynamic Light Scattering for Aggregation Detection

May 15, 2013

Wyatt - Automated Dynamic Light Scattering for Aggregation Detection

Report Previews Future of U.S. Biosimilar Market

May 15, 2013

Thomson Reuters released a report that provides a view of the challenges facing companies entering the United States biosimilar drug market.

Amgen Forms New Joint Venture to Commercialize Vectibix in China

May 13, 2013

Amgen and Zhejiang Beta Pharma have signed an agreement to form a joint venture to commercialize Amgen's Vectibix (panitumumab) in the Chinese market. The aim is to quickly and efficiently deliver Vectibix to patients in China. Vectibix is a fully human anti-epidermal growth factor receptor (EGFR) antibody approved by FDA for the treatment of metastatic colorectal cancer.

Tamiflu Leads Q1 Drug Sales Growth

May 7, 2013

In the first quarter of 2013, the rankings for the top five drugs by sales shifted a bit, but exhibited positive growth for the quarter.

ADVERTISEMENT

ADVERTISEMENT

Click here